Correlation Between Biotechnology Fund and Monthly Rebalance
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Monthly Rebalance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Monthly Rebalance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Monthly Rebalance Nasdaq 100, you can compare the effects of market volatilities on Biotechnology Fund and Monthly Rebalance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Monthly Rebalance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Monthly Rebalance.
Diversification Opportunities for Biotechnology Fund and Monthly Rebalance
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Biotechnology and Monthly is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Monthly Rebalance Nasdaq 100 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monthly Rebalance and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Monthly Rebalance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monthly Rebalance has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Monthly Rebalance go up and down completely randomly.
Pair Corralation between Biotechnology Fund and Monthly Rebalance
Assuming the 90 days horizon Biotechnology Fund Class is expected to generate 0.44 times more return on investment than Monthly Rebalance. However, Biotechnology Fund Class is 2.3 times less risky than Monthly Rebalance. It trades about 0.18 of its potential returns per unit of risk. Monthly Rebalance Nasdaq 100 is currently generating about -0.01 per unit of risk. If you would invest 5,550 in Biotechnology Fund Class on November 5, 2024 and sell it today you would earn a total of 203.00 from holding Biotechnology Fund Class or generate 3.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biotechnology Fund Class vs. Monthly Rebalance Nasdaq 100
Performance |
| Timeline |
| Biotechnology Fund Class |
| Monthly Rebalance |
Biotechnology Fund and Monthly Rebalance Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biotechnology Fund and Monthly Rebalance
The main advantage of trading using opposite Biotechnology Fund and Monthly Rebalance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Monthly Rebalance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monthly Rebalance will offset losses from the drop in Monthly Rebalance's long position.| Biotechnology Fund vs. Dunham Real Estate | Biotechnology Fund vs. Vanguard Reit Index | Biotechnology Fund vs. Baron Real Estate | Biotechnology Fund vs. Fidelity Real Estate |
| Monthly Rebalance vs. Growth Portfolio Class | Monthly Rebalance vs. Eip Growth And | Monthly Rebalance vs. Stringer Growth Fund | Monthly Rebalance vs. Qs Defensive Growth |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |